Skip to Main Content

Paper Details

Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer.
Clin Lung Cancer
14
2019
Author NameAffiliation
Suzanne Kamel-ReidUniversity Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network and Department of Medicine, University of Toronto
Melania PintiliePrincess Margaret Cancer Centre
Ming-Sound TsaoUniversity Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto
Frances A ShepherdPrincess Margaret Cancer Centre, University Health Network and Department of Medicine, University of Toronto
  • 1 - 5

Datasets